The Current Ratio as of November 2024 (TTM) for Hillstream BioPharma, Inc. (HILS) is 2.25

According to Hillstream BioPharma, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.25. This represents a change of -36.72% compared to the average of 3.55 of the last 4 quarters.

Hillstream BioPharma, Inc. (HILS) Historical Current Ratio (quarterly & annually)

How has HILS Current Ratio performed in the past?

The mean historical Current Ratio of Hillstream BioPharma, Inc. over the last ten years is 2.43. The current 2.25 Current Ratio has changed 9.14% with respect to the historical average. Over the past ten years (40 quarters), HILS's Current Ratio was at its highest in in the June 2022 quarter at 13.13. The Current Ratio was at its lowest in in the September 2020 quarter at 0.

Hillstream BioPharma, Inc. (HILS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Hillstream BioPharma, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Hillstream BioPharma, Inc. (HILS) Average Current Ratio

How has HILS Current Ratio performed in the past?

The current Current Ratio of Hillstream BioPharma, Inc. (HILS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Hillstream BioPharma, Inc. (HILS) Current Ratio vs. Peers

How is HILS’s Current Ratio compared to its peers?

Hillstream BioPharma, Inc.’s Current Ratio is less than Virax Biolabs Group Limited (0), less than Blue Water Vaccines, Inc. (25.94), greater than Revelation Biosciences, Inc. (0.54), greater than Kiora Pharmaceuticals, Inc. (1.64), less than ZyVersa Therapeutics, Inc. (8.97), greater than Palisade Bio, Inc. (0.03), less than Unicycive Therapeutics, Inc. (3.31), less than Apexigen, Inc. (3.61), greater than Immix Biopharma, Inc. (1.29), less than Quoin Pharmaceuticals, Ltd. (3.47), less than PaxMedica, Inc. Common Stock (3.02), greater than Cardio Diagnostics Holdings, Inc. (0.38), less than null (8.51),

Build a custom stock screener for Hillstream BioPharma, Inc. (HILS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hillstream BioPharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hillstream BioPharma, Inc. (HILS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hillstream BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.